Aclaris Therapeutics
Price & Volume
Stats
See more52W Range | $0.59-$5.60 |
Market Cap | $149.1M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $32M |
Revenue Growth (YoY) | 48% |
Gross Profit (12 Mos) | -$60M |
Diluted EPS | -$0.82 |
News
See moreYahoo Finance • 9 months ago
15 Small-Cap Stocks with High Potential
Yahoo Finance • 12 months ago
Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update
Yahoo Finance • last year
Aclaris Therapeutics Inc (ACRS) Reports Q3 2023 Financial Results
Yahoo Finance • last year
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
About
CEO | Dr. Neal S. Walker D.O., M.D. |
Address | 701 Lee Road, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 86 |
